Jie Wang
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 2%
- Immunology top 5%
- Topics
- Lung Cancer Treatments and Mutations (115 papers)Cancer Immunotherapy and Biomarkers (89 papers)Lung Cancer Research Studies (65 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jie Wang
328 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Oncology 3.8k
- Pulmonary and Respiratory Medicine 2.9k
- Molecular Biology 1.9k
- Cancer Research 907
- Immunology 801
Countries citing papers authored by Jie Wang
This map shows the geographic impact of Jie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Wang more than expected).
Fields of papers citing papers by Jie Wang
This network shows the impact of papers produced by Jie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Wang. The network helps show where Jie Wang may publish in the future.
Co-authorship network of co-authors of Jie Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Wang. A scholar is included among the top collaborators of Jie Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Wang. Jie Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 5 | |
| 3 | 12 | |
| 4 | 13 | |
| 5 | 22 | |
| 6 | 8 | |
| 7 | 4 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 3 | |
| 11 | 15 | |
| 12 | 4 | |
| 13 | 3 | |
| 14 | 8 | |
| 15 | 15 | |
| 16 | 177 | |
| 17 | 10 | |
| 18 | 47 | |
| 19 | [Prognostic factors and response of chemotherapy including amrubicin in small cell lung cancer patients]. | 1 |
| 20 | 22 |
About Jie Wang
Jie Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 346 papers that have together received 6.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (115 papers), Cancer Immunotherapy and Biomarkers (89 papers) and Lung Cancer Research Studies (65 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (2.9k citations) and Cancer Research (907 citations). Jie Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhijie Wang, Hua Bai, Jianchun Duan, Jie He, Kailun Fei, Jianchun Duan, Ying Cheng, Hua Bai, Shun Lü and Jianying Zhou. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.